Growth of Sanner Group's Medical Device Portfolio
Sanner Group is making important strides to strengthen its position in the global healthcare market by acquiring Gilero LLC. This strategic decision is designed to enhance Sanner's wide array of development and manufacturing services within the medical device sector.
What the Gilero Acquisition Means for Sanner
By welcoming Gilero into its array of offerings, Sanner establishes itself as a top-tier provider of integrated services across both drug delivery and medical technology areas. With Gilero’s strengths in design, assembly, packaging, and contract manufacturing, Sanner is now equipped to deliver a more cohesive and all-encompassing service model to its clients. This acquisition not only boosts Sanner’s capabilities but also broadens its operational reach in vital markets.
Enhancements in Expertise and Capability
Gilero is well-known for its robust capabilities in developing medical devices and drug delivery systems. This expertise is poised to significantly enhance Sanner’s service offerings, enabling a seamless progression from design right through to production. With its operations spanning across the United States, Mexico, and Ireland, Gilero’s global presence complements Sanner’s existing facilities, thereby strengthening its international footprint.
Leadership Insights
Hans-Willem van Vliet, Sanner's CEO, shared his enthusiasm regarding this acquisition, emphasizing that Gilero aligns perfectly with Sanner's goal of becoming a leading global provider of tailored medical technology solutions. He remarked that this acquisition would enhance the company's ability to serve its clients better and address supply chain challenges by having production closer to important markets.
Sanner's Vision Moving Forward
Sanner sets its sights on establishing a next-generation contract development and manufacturing organization (CDMO) for medical devices, focused on agility and innovative solutions. This ambition is deeply rooted in Sanner’s long-standing tradition in the healthcare packaging sector, especially known for its exceptional desiccant packaging solutions.
Expanding Global Manufacturing Capabilities
Acquiring Gilero is a key part of Sanner's plan to enhance its end-to-end CDMO operations globally. With new facilities in the US and developments underway in Germany and Asia, Sanner is well-positioned to stand out in the medical device and pharmaceutical sectors.
Guidance During the Acquisition
Sanner received expert guidance throughout the acquisition process, including financial advice from Alvarez & Marsal, tax structuring assistance from Deloitte, and legal counsel from Norton Rose Fulbright. Similarly, Gilero was supported by Alira Health and Hutchison PLLC for legal matters.
About Sanner
Founded in 1894, Sanner GmbH has established itself as a leader in healthcare packaging solutions worldwide. With a strong manufacturing presence in several countries such as Germany, France, and the US, Sanner has transitioned from being a market leader in desiccant closures to a versatile provider of customized solutions in the medical device arena. Sanner currently serves over 150 countries and employs more than 750 staff members globally.
About Gilero
Gilero focuses on delivering end-to-end services in the medical device and drug delivery markets. With a dedicated team of over 130 skilled professionals based in North Carolina, California, Illinois, and Ireland, Gilero is committed to innovation, ensuring it remains a valuable partner in healthcare solutions by providing high-quality design and engineering services.
Frequently Asked Questions
What is the significance of Sanner acquiring Gilero?
The acquisition allows Sanner to boost its capabilities in the medical device sector while also strengthening its global manufacturing presence.
Where is Gilero located?
Gilero's headquarters is in Durham, North Carolina, with additional offices in Carlsbad, California, Chicago, Illinois, and Athlone, Ireland.
How will this acquisition impact Sanner's services?
This acquisition will broaden Sanner's service offerings, enabling more integrated solutions in drug delivery and medical device development.
What markets will Sanner expand into through this acquisition?
Sanner plans to enhance its operations mainly in the US and Mexico, which are key hubs for biopharma and medical technology.
What is Sanner's history?
Founded over 125 years ago, Sanner has evolved from being a leader in pharmaceutical packaging to focusing on innovative medical device solutions and worldwide CDMO services.
